Abstract
BackgroundResearch and development (R&D) of new drugs and regimens against tuberculosis (TB) is evolving to meet new challenges and face limited investments in the sector. To effectively improve and fill...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have